NO945032D0 - Fremgangsmåte for fremstilling av et konsentrat av Anti-D-Immunglobulin D samt farmasöytisk preparat inneholdende dette - Google Patents

Fremgangsmåte for fremstilling av et konsentrat av Anti-D-Immunglobulin D samt farmasöytisk preparat inneholdende dette

Info

Publication number
NO945032D0
NO945032D0 NO945032A NO945032A NO945032D0 NO 945032 D0 NO945032 D0 NO 945032D0 NO 945032 A NO945032 A NO 945032A NO 945032 A NO945032 A NO 945032A NO 945032 D0 NO945032 D0 NO 945032D0
Authority
NO
Norway
Prior art keywords
igg
adsorbent
plasma
immunoglobulin
concentrate
Prior art date
Application number
NO945032A
Other languages
English (en)
Other versions
NO945032L (no
NO315331B1 (no
Inventor
Gerhard Hodler
Peter Lerch
Martin Stucki
Original Assignee
Rotkreuzstiftung Zentrallab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8215103&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO945032(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Rotkreuzstiftung Zentrallab filed Critical Rotkreuzstiftung Zentrallab
Publication of NO945032D0 publication Critical patent/NO945032D0/no
Publication of NO945032L publication Critical patent/NO945032L/no
Publication of NO315331B1 publication Critical patent/NO315331B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/34—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood group antigens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
NO19945032A 1993-12-27 1994-12-23 Fremgangsmate for fremstilling av et konsentrat av anti-D- immunglobulin G samt farmasoytisk preparat inneholdende dette NO315331B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP93810912A EP0659767B2 (de) 1993-12-27 1993-12-27 Verfahren zur Herstellung eines Konzentrates von Anti-D-Immunoglobulin G und pharmazeutische Zusammensetzung, die dieses enthält

Publications (3)

Publication Number Publication Date
NO945032D0 true NO945032D0 (no) 1994-12-23
NO945032L NO945032L (no) 1995-06-28
NO315331B1 NO315331B1 (no) 2003-08-18

Family

ID=8215103

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19945032A NO315331B1 (no) 1993-12-27 1994-12-23 Fremgangsmate for fremstilling av et konsentrat av anti-D- immunglobulin G samt farmasoytisk preparat inneholdende dette

Country Status (20)

Country Link
US (1) US5593675A (no)
EP (1) EP0659767B2 (no)
JP (1) JP2926463B2 (no)
KR (1) KR100368563B1 (no)
AT (1) ATE175979T1 (no)
AU (1) AU682243B2 (no)
CA (1) CA2138921C (no)
CZ (1) CZ286271B6 (no)
DE (1) DE59309332D1 (no)
DK (1) DK0659767T4 (no)
ES (1) ES2129076T5 (no)
FI (1) FI112168B (no)
GR (1) GR3029817T3 (no)
HU (1) HU216864B (no)
NO (1) NO315331B1 (no)
NZ (1) NZ278057A (no)
PL (1) PL180358B1 (no)
SI (1) SI9420008B (no)
TW (1) TW311884B (no)
WO (1) WO1995018155A1 (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU760048B2 (en) * 1998-05-06 2003-05-08 Genentech Inc. Protein purification by ion exchange chromatography
DK2270044T3 (en) * 1998-06-09 2015-01-26 Csl Behring Ag Liquid immunoglobulin G (IgG) product
DE19923027C2 (de) * 1999-05-19 2002-09-19 Aventis Behring Gmbh Verfahren zur Inaktivierung von Viren
US6475749B1 (en) * 1999-08-11 2002-11-05 The Regents Of The University Of California Rh hybrid antibody
SE0001128D0 (sv) * 2000-03-30 2000-03-30 Amersham Pharm Biotech Ab A method of producing IgG
ES2184594B1 (es) * 2001-01-17 2004-01-01 Probitas Pharma Sa Procedimiento para la produccion de gammaglobulina g humana inactivada de virus.
EP1532983A1 (en) * 2003-11-18 2005-05-25 ZLB Bioplasma AG Immunoglobulin preparations having increased stability
CA2458750C (en) 2004-02-23 2012-02-07 Bayer Inc. Isoolefin-diolefin production process and apparatus therefor
CA2607281C (en) * 2005-05-05 2023-10-03 Duke University Anti-cd19 antibody therapy for autoimmune disease
TWI320788B (en) 2005-05-25 2010-02-21 Hoffmann La Roche Method for the purification of antibodies
EP2061803B2 (en) * 2006-08-28 2022-11-16 Ares Trading S.A. Process for the purification of fc-containing proteins
US20100267932A1 (en) * 2006-08-28 2010-10-21 Alex Eon-Duval Process for the purification of fc-fusion proteins
IT1397061B1 (it) * 2009-12-28 2012-12-28 Kedrion Spa Nuovo processo di purificazione su scala industriale di gammaglobuline da plasma umano per uso industriale.
PL2531218T3 (pl) 2010-02-04 2019-05-31 Csl Behring Ag Preparat immunoglobuliny
EP2361636A1 (en) 2010-02-26 2011-08-31 CSL Behring AG Immunoglobulin preparation and storage system for an immunoglobulin preparation
RU2467783C2 (ru) * 2010-07-30 2012-11-27 Закрытое акционерное общество "БиоХимМак СТ" Способ хроматографического выделения иммуноглобулина
US8795658B2 (en) * 2010-09-17 2014-08-05 Baxter International Inc. Stabilization of immunoglobulins through aqueous formulation with histidine at weak acidic to neutral pH
CN103874708B (zh) * 2011-08-26 2018-07-10 百深有限责任公司 用于降低血浆来源免疫球蛋白组合物的血栓栓塞可能性的方法
AU2013203043B2 (en) * 2013-03-15 2016-10-06 Takeda Pharmaceutical Company Limited Methods to produce a human plasma-derived igg preparation enriched in brain disease-related natural iggs
EP3118210B1 (en) * 2014-03-11 2019-11-13 Green Cross Holdings Corporation Method for purifying immunoglobulin
ES2785375T3 (es) * 2014-03-11 2020-10-06 Green Cross Holdings Corp Procedimiento de purificación de inmunoglobulina
EP4349859A1 (en) * 2023-01-27 2024-04-10 CSL Behring AG Method to purify anti-d immunoglobulin g from plasma

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3869436A (en) * 1971-06-01 1975-03-04 Statens Bakteriologiska Lab Method for fractionating plasma proteins using peg and ion-exchangers
EP0085747B2 (de) * 1982-02-08 1990-05-30 Schweizerisches Serum- und Impfinstitut und Institut zur Erforschung der Infektionskrankheiten Intravenös verabreichbares humanes Immunglobulin und Verfahren zu dessen Herstellung
US4434093A (en) * 1982-07-26 1984-02-28 Ortho Diagnostic Systems Inc. Methods for preparation of HBs Ag free gamma globulins
DE3640513A1 (de) * 1986-11-27 1988-06-09 Biotest Pharma Gmbh Verfahren zur herstellung eines virussicheren, lagerstabilen und intravenoes vertraeglichen immunglobulin-g-praeparates
US5118796A (en) * 1987-12-09 1992-06-02 Centocor, Incorporated Efficient large-scale purification of immunoglobulins and derivatives
US5138034A (en) * 1989-07-12 1992-08-11 The Green Cross Corporation Method of fractionating plasma proteins
US5177194A (en) * 1990-02-01 1993-01-05 Baxter International, Inc. Process for purifying immune serum globulins

Also Published As

Publication number Publication date
PL310435A1 (en) 1995-12-11
DK0659767T3 (da) 1999-09-13
US5593675A (en) 1997-01-14
JPH07206708A (ja) 1995-08-08
PL180358B1 (pl) 2001-01-31
WO1995018155A1 (en) 1995-07-06
AU1414395A (en) 1995-07-17
HU216864B (hu) 1999-09-28
EP0659767A1 (de) 1995-06-28
FI946103A0 (fi) 1994-12-27
KR960701098A (ko) 1996-02-24
DK0659767T4 (da) 2003-02-10
ES2129076T3 (es) 1999-06-01
JP2926463B2 (ja) 1999-07-28
SI9420008B (sl) 1998-06-30
ES2129076T5 (es) 2003-05-16
GR3029817T3 (en) 1999-06-30
CA2138921A1 (en) 1995-06-28
CZ286271B6 (cs) 2000-03-15
TW311884B (no) 1997-08-01
DE59309332D1 (de) 1999-03-04
FI946103A (fi) 1995-06-28
HU9502514D0 (en) 1995-11-28
FI112168B (fi) 2003-11-14
EP0659767B2 (de) 2002-11-06
NO945032L (no) 1995-06-28
KR100368563B1 (ko) 2003-04-03
AU682243B2 (en) 1997-09-25
CA2138921C (en) 2004-11-02
ATE175979T1 (de) 1999-02-15
CZ249295A3 (en) 1996-01-17
NO315331B1 (no) 2003-08-18
NZ278057A (en) 1997-03-24
HUT73376A (en) 1996-07-29
SI9420008A (en) 1996-02-29
EP0659767B1 (de) 1999-01-20

Similar Documents

Publication Publication Date Title
NO945032L (no) Fremgangsmåte for fremstilling av et konsentrat av Anti-D-Immunglobulin D samt farmasöytisk preparat inneholdende dette
EP0352500A3 (en) Polyclonal immunoglobulin-based intravenous preparation with a high igm content, and method for its production
CA2183888A1 (en) Antibody purification
CA2214633A1 (en) Antibody purification by low-ph hydrophobic interaction chromatography
NZ330061A (en) Process for recovering growth factors from milk or a milk derivative by separating out an growth factor enriched fraction and then further treating this fraction
CA2128111A1 (en) Process for Isolating Lactoferrin and Lactoperoxidase from Milk and Milk Products, and Products Obtained by Such Process
AU638969B2 (en) Pasteurized, purified von willebrand factor concentrate and a process for the preparation thereof
EP0530447A3 (en) Process for purifying igg monoclonal antibodies and their use
HUT64777A (en) Method for producing virus-safe vii factor of high purity
DE3914869C1 (no)
CS275600B2 (en) Method of purified albumin preparation from human or animal physiological solution
DE3479503D1 (en) Process for the preparation of an antithrombin iii-heparin, e.g. an antithrombin iii-heparinoid concentrate
CA2213577A1 (en) A process for the preparation of factor ix from biological sources
HU9602570D0 (en) Process for producing immunoglobulines from fractions produced with fractioning human blood-plasma
DE555135T1 (de) Verfahren zur Herstellung von hochreinem Fibrinogen, hochreines Fibrinogen so erhalten und dieses enthaltende pharmazeutische Zusammensetzung.
CA2096888A1 (en) Process for the inactivation of viruses in preparations of proteins
DE4229876A1 (de) Verfahren zur Gewinnung von Lektinen aus Mistelpflanzen
EP0766697A1 (de) Verfahren zur isolierung von isolektinen aus der mistel
HK1007747A1 (en) Interferon purification process
GB9001593D0 (en) Thiophilic absorbents
RU93009368A (ru) Способ получения микрогранулированной целлюлозы, сорбенты на ее основе для выделения и очистки ферментных препаратов и способ очистки стрептокиназы

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees